ArticleClinical drug investigation2022

Correction to: Effects of Galcanezumab on Health-Related Quality of Life and Disability in Patients with Previous Failure of 2-4 Migraine Preventive Medication Categories: Results from a Phase IIIb Randomized, Placebo-Controlled, Multicenter Clinical Trial (CONQUER).

Stewart J Tepper et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.